Patients with severe left ventricular dysfunction undergoing TAVI for aortic stenosis who experience an improvement in their ventricle’s function achieve mid-term mortality similar to that seen among ...

Echocardiography can identify a range of cardiac abnormalities in COVID-19 patients who have biomarkers indicative of myocardial injury, a new study shows. Importantly, the combination of both ...

In patients with severe left ventricular systolic dysfunction on optimal medical therapy for HF, undergoing PCI did not improve rates of all-cause death or HF hospitalization, according to the results ...

Vancouver, BC - The PET and Recovery Following Revascularization (PARR-2) trial showed that, among patients with severe left ventricular (LV) dysfunction, those who received fluorodeoxyglucose (FDG) ...

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease ...

Please provide your email address to receive an email when new articles are posted on . Key risk factors that may predict severe disease in patients with MIS-C include fever greater than 103.1 degrees ...

In a recent study published in the Journal of Critical Care, researchers assessed the cardiac function in patients experiencing severe coronavirus disease 2019 (COVID-19). Study: Cardiac function in ...

Because life expectancy and the prevalence of risk factors such as hypertension, obesity and diabetes are rising globally, heart failure (HF) is growing into a major health problem. Impairment of left ...

Recently, while preparing an updated presentation to the Saint Louis University cardiology fellows on "diastolic dysfunction," the Skeptical Cardiologist came across a document entitled "What Does ...